Certara Investor Presentation Deck
Certara at a Glance
BUSINESS
20+ Year
History of innovation
1,100+ Employees(1)
350+ with Ph.D.s,
Pharm.D.s and M.D.s
16 Acquisitions
Track record of accretive,
complementary
acquisitions
(1) As of 12/31/2021
(2) Market research reports from Grand View and SpendEdge
(3) Customer data as of 12/31/2021
(4) See Appendix for reconciliation tables
© Copyright 2022 Certara, Inc. All rights reserved.
●
●
●
END-TO-END PLATFORM
Software
●
Biosimulation
Regulatory & compliance
Market access
Technology-Driven Services
• Drug discovery & development
with biosimulation
• Regulatory science
Market access
$13B TAM growing at
12-16% CAGR(²)
CUSTOMERS(3)
2,000+
Customers across
62 countries
10+ Year
Average tenure
for top 30 customers
299 customers with
ACV > $100,000
(15% growth YoY)
1Q 2022 FINANCIALS
$81.6M Revenue
22% YoY Growth
(13% excl. Pinnacle 21)
Net Income $2.2M
PY $1.1M
$27.7M
Adjusted EBITDA(4)
16% YoY Growth
34% Adjusted EBITDA
Margin
4
CERTARAView entire presentation